An MYC-Driven Vicious Circuit Is a Targetable Achilles' Heel in Lymphoma

被引：1
|
作者：
Wilson, Erica B. [1 ]
Klein, Ulf [1 ,2 ]
机构：
[1] Univ Leeds, Leeds Inst Med Res St Jamess, Leeds, England
[2] Univ Leeds, Leeds Inst Med Res St Jamess, Leeds LS9 7TF, England
来源：
BLOOD CANCER DISCOVERY | 2023年 / 4卷 / 04期
关键词：
D O I：
10.1158/2643-3230.BCD-23-0053
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In this issue of Blood Cancer Discovery, Nakanishi et al. uncover a critical role for the elevated activity of the translation initiation factor eIF5A in the malignant growth of MYC-driven lymphoma. eIF5A is posttrans-lationally modifi ed by hypusination through MYC oncoprotein-mediated hyperactivation of the polyamine- hypusine circuit, which may represent a promising therapeutic target because an enzyme of this circuit that is required for hypusinating eIF5A proved to be essential for lymphoma development.
引用
收藏
页码：248 / 251
页数：4
相关论文
共 50 条
  • [21] Mnt modulates Myc-driven lymphomagenesis
    Campbell, Kirsteen J.
    Vandenberg, Cassandra J.
    Anstee, Natasha S.
    Hurlin, Peter J.
    Cory, Suzanne
    CELL DEATH AND DIFFERENTIATION, 2017, 24 (12): : 2117 - 2126
  • [22] A Vulnerable Side to MYC-Driven Cancers
    不详
    CANCER DISCOVERY, 2015, 5 (11) : 1116 - 1116
  • [23] Oxidative stress enhances the therapeutic action of a respiratory inhibitor in MYC-driven lymphoma
    Donati, Giulio
    Nicoli, Paola
    Verrecchia, Alessandro
    Vallelonga, Veronica
    Croci, Ottavio
    Rodighiero, Simona
    Audano, Matteo
    Cassina, Laura
    Ghsein, Aya
    Binelli, Giorgio
    Boletta, Alessandra
    Mitro, Nico
    Amati, Bruno
    EMBO MOLECULAR MEDICINE, 2023, 15 (06)
  • [24] Investigating the role of PD-L1 expression in MYC-driven lymphoma
    Brugger, M.
    Gruen, J.
    Steidle, S.
    Keller, U.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 71 - +
  • [25] Mnt modulates Myc-driven lymphomagenesis
    Kirsteen J Campbell
    Cassandra J Vandenberg
    Natasha S Anstee
    Peter J Hurlin
    Suzanne Cory
    Cell Death & Differentiation, 2017, 24 : 2117 - 2126
  • [26] An Animal Model of MYC-Driven Medulloblastoma
    Pei, Yanxin
    Moore, Colin E.
    Wang, Jun
    Tewari, Alok K.
    Eroshkin, Alexey
    Cho, Yoon-Jae
    Witt, Hendrik
    Korshunov, Andrey
    Read, Tracy-Ann
    Sun, Julia L.
    Schmitt, Earlene M.
    Miller, C. Ryan
    Buckley, Anne F.
    McLendon, Roger E.
    Westbrook, Thomas F.
    Northcott, Paul A.
    Taylor, Michael D.
    Pfister, Stefan M.
    Febbo, Phillip G.
    Wechsler-Reya, Robert J.
    CANCER CELL, 2012, 21 (02) : 155 - 167
  • [27] Therapeutic targets for MYC-driven cancers
    Laffman-Johnson, Elise
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 92 (03) : 272 - 272
  • [28] ID3 Loss In Vivo Synergizes with MYC-Driven Oncogenesis in Burkitt Lymphoma
    Love, Cassandra
    Remple, Rachel
    Li, Guojie
    Dave, Sandeep
    BLOOD, 2015, 126 (23)
  • [29] BCL-W makes only minor contributions to MYC-driven lymphoma development
    Diepstraten, Sarah T.
    La Marca, John E.
    Chang, Catherine
    Young, Savannah
    Strasser, Andreas
    Kelly, Gemma L.
    ONCOGENE, 2023, 42 (37) : 2776 - 2781
  • [30] Phosphoglycerate Dehydrogenase Is Required for Germinal Center Formation and Is a Therapeutic Target in MYC-driven Lymphoma
    D'Avola, Annalisa
    Legrave, Nathalie
    Tajan, Mylene
    Chakravarty, Probir
    Shearer, Ryan
    King, Hamish
    Cheung, Eric
    Clear, Andrew James
    Gunawan, Arief Suryono
    Zhang, Lingling
    James, Louisa
    MacRae, James
    Gribben, John
    Calado, Dinis Pedro
    Vousden, Karen
    Riches, John C.
    BLOOD, 2021, 138
12345